CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients

Arthritis and Rheumatism

Volumn 60, Issue 1, 2009, Pages 199-206

  Enghard, P ^a   Humrich, J Y ^a   Rudolph, B ^a   Rosenberger, S ^a   Biesen, R ^a   Kuhn, A ^b   Manz, R ^c   Hiepe, F ^a   Radbruch, A ^c   Burmester, G R ^a   Riemekasten, G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR3;

ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; DISEASE ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHRITIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; BIOLOGICAL MARKERS; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL10; EXTRACELLULAR FLUID; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LUPUS NEPHRITIS; RECEPTORS, CXCR3; URINE;

EID: 58249117641     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24136     Document Type: Article

References (27)

1. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994;330:1871-9.
2. Park MH, D'Agati V, Appel GB, Pirani CL. Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 1986;44:309-19.
3. Schwartz MM, Fennell JS, Lewis EJ. Pathologic changes in the renal tubule in systemic lupus erythematosus. Hum Pathol 1982;13:534-47.
4. Alexopoulos, E, Seron D, Hartley RB, Cameron JS. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 1990;37:100-9.
5. Magil AB, Tyler M. Tubulo-interstitial disease in lupus nephritis: a morphometric study. Histopathology 1984;8:81-7.
6. Jeruc J, Jurcic V, Vizjak A, Hvala A, Babic N, Kveder R, et al. Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesis. Wien Klin Wochenschr 2000;112:702-6.
7. Chan OT, Hammun LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999;189:1639-48.
8. Boucher A, Droz D, Adafer E, Noel LH. Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int 1986;29:1043-9.
9. Caligaris-Cappio F, Bergui L, Tesio L, Ziano R, Camussi G. HLA-DR+ T cells of the Leu-3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus. Clin Exp Immunol 1985;59:185-9.
10. Cassese G, Lindenau S, de Boer B, Arce S, Hauser A, Riemekasten G, et al. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur J Immunol 2001;31:2726-32.
11. Bonecchi, R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-34.
12. 1 mice. J Immunol 1998;160:3713-8.
13. lpr mice. J Immunol 1999;163:6884-91.
14. lpr mice. J Immunol 1998;161:494-503.
15. Perez de Lema G, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, et al. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 2001;12:1369-82.
16. Hauser AE, Debes GF, Arce S, Cassese G, Hamann A, Radbruch A, et al. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J Immunol 2002;169:1277-82.
17. Narumi S, Takeuchi T, Kobayashi Y, Konishi K. Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus. Cytokine 2000;12:1561-5.
18. Avihingsanon Phumesin P, Benjachat T, Akkasilpa S, Kittikowit V, Praditpornsilpa K, Wongpiyabavorn J, et al. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis. Kidney Int 2006;69:747-53.
19. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
20. Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 2003;197:1537-49.
21. Segerer S, Banas B, Wornle M, Schmid H, Cohen CD, Kretzler M, et al. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 2004;164:635-49.
22. Flier J, Boorsma DM, van Beek PJ, Nieboer C, Stoof TJ, Willemze R, et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001;194:398-405.
23. Wenzel J, Worenkamper E, Freutel S, Henze S, Haller O, Bieber T, et al. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol 2005;205:435-42.
24. Hancock WW, Lu B, Gao W, Csizmadia V, Faia K, King JA, et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000;192:1515-20.
25. Mohan K, Cordeiro E, Vaci M, McMaster C, Issekutz TB. CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets. Eur J Immunol 2005;35:1702-11.
26. Panzer U, Steinmetz OM, Paust HJ, Meyer-Schwesinger C, Peters A, Turner JE, et al. Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J Am Soc Nephrol 2007;18:2071-84.
27. Rovin BH, Birmingham DJ, Nagara HN, Yu C, Hebert LA. Biomarker discovery in human SLE nephritis. Bull N Y U Hosp Jt Dis 2007;65:187-93.